UBX - Unity Biotechnology EPS beats by $0.09 November, 10 2021 08:32 AM Unity Biotechnology Inc. Unity Biotechnology (NASDAQ:UBX): Q3 GAAP EPS of -$0.30 beats by $0.09. Cash, cash equivalents, and marketable securities totaled of $88.5M Press Release For further details see: Unity Biotechnology EPS beats by $0.09